Abstract:Juvenile Idiopathic Arthritis (JIA) is the most common type of arthritis among children, encompassing a highly heterogeneous group of immune-mediated joint disorders, being classified into seven subtypes based on clinical presentation. To systematically understand the distinct and shared genetic underpinnings of JIA subtypes, we conducted a heterogeneity-sensitive GWAS encompassing a total of 1245 JIA cases classified into 7 subtypes and 9250 controls. In addition to the MHC locus, we uncovered 16 genome-wide significant loci, among which 15 were shared between at least two JIA subtypes, including 11 novel loci. Functional annotation indicates that candidate genes at these loci are expressed in diverse immune cell types. Further, based on the association results, the 7 JIA subtypes were classified into two groups, reflecting their autoimmune vs autoinflammatory nature. Our results suggest a common genetic mechanism underlying these subtypes in spite of their different clinical disease phenotypes, and that there may be drug repositioning opportunities for rare JIA subtypes. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement The study was supported by Institutional Development Funds from the Children's Hospital of Philadelphia to the Center for Applied Genomics, The Children's Hospital of Philadelphia Endowed Chair in Genomic Research to HH, and the grant U01-HG006830 (NHGRI-sponsored eMERGE Network) to HH. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Research Ethics Boards of CHOP and other collaborating centers approved this study, and written informed consent was obtained from all subjects (or their legal guardians). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes To have access to the data reported in this manuscript, please contact the corresponding author Dr. Hakon Hakonarson.

A systematic strategy for identifying causal single nucleotide polymorphisms and their target genes on Juvenile arthritis risk haplotypes

Using Functional Genomic Data in Monocytes/Macrophages and Genotyping to Nominate Disease-Driving Single Nucleotide Polymorphisms and Target Genes in Juvenile Idiopathic Arthritis

Systematic Confirmation Study of GWAS-identified Genetic Variants for Kawasaki Disease in a Chinese Population.

Integrative analysis reveals novel insights into juvenile idiopathic arthritis pathogenesis and shared molecular pathways with associated traits

Juvenile idiopathic arthritis-associated genetic loci exhibit spatially constrained gene regulatory effects across multiple tissues and immune cell types

Association of novel rare coding variants with juvenile idiopathic arthritis

Revealing novel genomic insights and therapeutic targets for juvenile idiopathic arthritis through omics

Gene association analysis to determine the causal relationship between immune cells and juvenile idiopathic arthritis

Genetic association between the PTPN22, IRF5 and TYK2 gene variants and susceptibility to juvenile idiopathic arthritis

Using Genetics, Genomics, and Transcriptomics to Identify Therapeutic Targets in Juvenile Idiopathic Arthritis

Variants in CXCR4 associate with juvenile idiopathic arthritis susceptibility

Novel Association Strategy with Copy Number Variation for Identifying New Risk Loci of Human Diseases

Integrative Genetics Analysis of Juvenile Idiopathic Arthritis Identifies Novel Loci

Identification of candidate genes and pathways associated with juvenile idiopathic arthritis by integrative transcriptome-wide association studies and mRNA expression profiles

Genetic susceptibility to temporomandibular joint involvement in juvenile idiopathic arthritis

High-throughput identification of functional regulatory SNPs in systemic lupus erythematosus

Using the Attract Method to Identify Core Pathways in Juvenile Idiopathic Arthritis

Principles for the Post-Gwas Functional Characterisation of Risk Loci

Haplotype Analysis on the Relationship of the DNAJC6 Gene with Early-Onset Parkinson's Disease Risk in a Chinese Population.

Joint-tissue integrative analysis identifies high-risk genes for Parkinson's disease